Image of Mercedes Corina Becerra

Mercedes Becerra, Sc.D.

Jeffrey Cheah Professor of Global Health and Social Medicine, Harvard Medical School
Faculty Dean of Adams House, Faculty of Arts & Sciences

Mercedes C. Becerra, ScD, is the Jeffrey Cheah Professor of Global Health and Social Medicine at Harvard Medical School. She is also the Faculty Dean of Adams House at Harvard College.  Professor Becerra completed the AB degree at Harvard College in 1991 (History), followed by the MSc (Population and International Health) in 1993 and the DSc (Epidemiology) in 1999, both at the Harvard School of Public Health. 

For more than 25 years, Professor Becerra has conducted research focused on improving the treatment of drug-resistant tuberculosis (TB), strategies to estimate and detect TB in children, and strategies to treat and prevent TB in families exposed at home to this airborne infection. She sustains long-term collaborative partnerships with three international health delivery organizations: Partners In Health, IRD Global, and Advance Access & Delivery. Professor Becerra is co-founder of the Sentinel Project on Pediatric Drug-Resistant Tuberculosis— a network of clinicians, investigators, and advocates who collaborate to share evidence and resources that can increase children’s access to prompt and effective treatment.  Professor Becerra is also a co-founder of the Zero TB Initiative— a global consortium of local coalitions working to drive down TB rates, one community at a time.

Dr. Becerra's research focuses on the treatment and epidemiology of tuberculosis. She studies the burden of tuberculosis in the child and adult household contacts of tuberculosis patients. She also studies strategies to improve tuberculosis screening and treatment in children and high-risk households.

Complete list of Dr. Mercedes Becerra's publications on MyBibiliography.

Global and Regional Burden of Isoniazid-Resistant Tuberculosis.
Authors: Authors: Yuen CM, Jenkins HE, Rodriguez CA, Keshavjee S, Becerra MC.
Pediatrics
View full abstract on Pubmed
Towards early inclusion of children in tuberculosis drugs trials: a consensus statement.
Authors: Authors: Nachman S, Ahmed A, Amanullah F, Becerra MC, Botgros R, Brigden G, Browning R, Gardiner E, Hafner R, Hesseling A, How C, Jean-Philippe P, Lessem E, Makhene M, Mbelle N, Marais B, McIlleron H, McNeeley DF, Mendel C, Murray S, Navarro E, Anyalechi EG, Porcalla AR, Powell C, Powell M, Rigaud M, Rouzier V, Samson P, Schaaf HS, Shah S, Starke J, Swaminathan S, Wobudeya E, Worrell C.
Lancet Infect Dis
View full abstract on Pubmed
Additional drug resistance of multidrug-resistant tuberculosis in patients in 9 countries.
Authors: Authors: Kurbatova EV, Dalton T, Ershova J, Tupasi T, Caoili JC, Van Der Walt M, Kvasnovsky C, Yagui M, Bayona J, Contreras C, Leimane V, Via LE, Kim H, Akksilp S, Kazennyy BY, Volchenkov GV, Jou R, Kliiman K, Demikhova OV, Cegielski JP.
Emerg Infect Dis
View full abstract on Pubmed
Counting pyrazinamide in regimens for multidrug-resistant tuberculosis.
Authors: Authors: Franke MF, Becerra MC, Tierney DB, Rich ML, Bonilla C, Bayona J, McLaughlin MM, Mitnick CD.
Ann Am Thorac Soc
View full abstract on Pubmed
Counting pyrazinamide in regimens for multidrug-resistant tuberculosis.
Authors: Authors: Franke MF, Becerra MC, Tierney DB, Rich ML, Bonilla C, Bayona J, McLaughlin MM, Mitnick CD.
Ann Am Thorac Soc
View full abstract on Pubmed
Map the gap: missing children with drug-resistant tuberculosis.
Authors: Authors: Yuen CM, Rodriguez CA, Keshavjee S, Becerra MC.
Public Health Action
View full abstract on Pubmed
Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies.
Authors: Authors: Kurbatova EV, Cegielski JP, Lienhardt C, Akksilp R, Bayona J, Becerra MC, Caoili J, Contreras C, Dalton T, Danilovits M, Demikhova OV, Ershova J, Gammino VM, Gelmanova I, Heilig CM, Jou R, Kazennyy B, Keshavjee S, Kim HJ, Kliiman K, Kvasnovsky C, Leimane V, Mitnick CD, Quelapio I, Riekstina V, Smith SE, Tupasi T, van der Walt M, Vasilyeva IA, Via LE, Viiklepp P, Volchenkov G, Walker AT, Wolfgang M, Yagui M, Zignol M.
Lancet Respir Med
View full abstract on Pubmed
Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies.
Authors: Authors: Kurbatova EV, Cegielski JP, Lienhardt C, Akksilp R, Bayona J, Becerra MC, Caoili J, Contreras C, Dalton T, Danilovits M, Demikhova OV, Ershova J, Gammino VM, Gelmanova I, Heilig CM, Jou R, Kazennyy B, Keshavjee S, Kim HJ, Kliiman K, Kvasnovsky C, Leimane V, Mitnick CD, Quelapio I, Riekstina V, Smith SE, Tupasi T, van der Walt M, Vasilyeva IA, Via LE, Viiklepp P, Volchenkov G, Walker AT, Wolfgang M, Yagui M, Zignol M.
Lancet Respir Med
View full abstract on Pubmed
Evaluation of health-care providers' knowledge of childhood tuberculosis in Lima, Peru.
Authors: Authors: Chiang SS, Cruz AT, Del Castillo H, Contreras C, Becerra MC, Lecca L.
Paediatr Int Child Health
View full abstract on Pubmed
Cigarette smoking among tuberculosis patients increases risk of transmission to child contacts.
Authors: Authors: Huang CC, Tchetgen ET, Becerra MC, Cohen T, Galea J, Calderon R, Yataco R, Contreras C, Zhang ZB, Lecca L, Murray M.
Int J Tuberc Lung Dis
View full abstract on Pubmed